financetom
Business
financetom
/
Business
/
Eli Lilly signs research deal with AI-focused Genetic Leap
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly signs research deal with AI-focused Genetic Leap
Sep 6, 2024 1:02 PM

Sept 5 (Reuters) - Eli Lilly ( LLY ) has entered into a

research deal with artificial intelligence-focused firm Genetic

Leap for up to $409 million to develop genetic medicines, the

latter said on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved